Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population-Reference-Cited by-同舟云学术

Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population

Published:2015-09-01 Issue:S17 Volume:121 Page:3069-3079
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gou Lan-Ying¹²,Niu Fei-Yu¹²,Wu Yi-Long²,Zhong Wen-Zhao²

Affiliation:

1. Southern Medical University; Guangzhou Guangdong People's Republic of China

2. Guangdong Lung Cancer Institute; Guangdong General Hospital and Guangdong Academy of Medical Sciences; Guangzhou Guangdong People's Republic of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29531/fullpdf

Reference91 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin.,2011

2. Smoking and carcinoma of the lung; preliminary report;Doll;Br Med J.,1950

3. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985;Parkin;Int J Cancer.,1994

4. Nonsmall cell lung cancer in never smokers;Scagliotti;Curr Opin Oncol.,2009

5. Lung cancer in never smokers: change of a mindset in the molecular era;Lee;Lung Cancer.,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogene-Driven Non–Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations;Cancer Research;2024-04-08

2. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma;Cancer Genetics;2023-11

3. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR;Revue des Maladies Respiratoires Actualités;2023-10

4. Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposure;2023-07-06

5. Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma;Frontiers in Immunology;2023-06-26